jinri，fuxingkaitedecar-tchanpinajilunsaizhusheyezaiguoneihuopishangshi，chengweiguoneishougeshangshidecar-txibaoliaofayaowu。yucitongshi，yeneiduogecar-tyaowuxushidaifa：chuanqishengwu（legn.us）debcma car-tchanpinyouwangyujinnianxiabannianzaimeishangshi；yaomingjunuo-b（02126.hk）dejwcar029yihuode“youxianshenping”he“tupoxingyaowu”liangxiangjiasushenpingzige，muqianchuyushenpijinchengzhong；kejiyaoye-b（02171.hk）decar-tliaofazeyihuozhong、mei、jiasanguo7gelinchuangshiyanxuke。
毫无疑问，国内CAR-T市场正进入高速发展快车道。与此同时，相关资本与风投对这个新医药赛道上的机会也逐步增温：高瓴刚刚80亿港元入股金斯瑞生物和其旗下的CAR-T厂商传奇生物，以及细胞基因CDMO公司金斯瑞蓬勃生物；而早在今年4月，高瓴还参与了总额4亿元的博腾生物A轮融资。
yicar-tweidaibiaodexibaojiyinzhiliaoshidaiyirankaiqi。duiyuzheipianweilai8nianfuhenianzengzhanglvkeda45%delanhai，shichangjianghenkuairenshiqizhongqianzaidejudajiazhi。
下一代肿瘤治疗新范式：细胞基因治疗
xibaojiyinzhiliaoyebeichengzuojiyuxibaodejiyinliaofa(cell-based gene therapy)。muqian，cileiliaofadezhuliushishifangshishiquconghuanzhetineitiqutedingxibao，jingjiyingongchenggaizao，zaihuishuyiyongyujibingzhiliao。jingjiyingongchenggaizaohoudexibaokenengjubeiduozhonggongxiao，ruduibingzaodebaxiangxing、dafutishengdemianyigongnengdeng。
细胞基因治疗更倾向于通过极少的剂次、在极短的疗程中解决其适应症，通常只需一针就能获得比传统治疗更好的效果。其中，有不少方案展现了对癌症的出众疗效，甚至治愈。因此，细胞基因治疗方案有很大潜力成为继单抗、双抗、ADC等明星药物后的下一代抗癌疗法。
car-t，qianhekangyuanshoutitxibaomianyiliaofa（chimeric antigen receptor t-cellimmuno therapy），yichengweixibaojiyinliaofadedianxingdaibiao。gailiaofashouxianjiangshibiezhongliuxiangguankangyuandescfvhebaoneixinhaoyu(tongchangweicd3ζhuofcεriγ)zaitiwaijinxingjiyinzhongzu，ranhoutongguogongchengfangfajiangzhongzuchanwuqinranqianhedaohuanzhetxibaozhong，shihuanzhetxibaobiaodazhongliukangyuanshouti。jingguochunhuahedaguimokuozenghouhuishudetxibao（kechengweicar-txibao），kezaihuanzhetineiduizhongliuchanshengjigaoxiaodeteyixingmianyi。